Home › Trial NCT06100705
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
- Trial IDNCT06100705
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorYale University
- Enrollment26
- Start date2023-12-20
- ConditionsMetastatic Castration-resistant Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.